Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium

Fig. 2

Metformin induces MSC apoptosis. a Diabetic mice were administered with PBS or metformin by gavage for 4 weeks, and then all mice were sacrificed to isolate mouse bone marrow mesenchymal stem cells (mBMSCs) for flow cytometry assay. b, c In vivo effects of metformin on mBMSCs. Compared with the PBS group, metformin decreased the number of mBMSCs (CD45−/CD105+/CD29+/Sca-1+). Lines in c represent the mean. **p < 0.01, by t test, n = 10. mBMSC, mouse bone marrow mesenchymal stromal cell. d, e Human umbilical cord MSC apoptosis ratio (annexin V+) induced by different concentrations of metformin at 24 h, 48 h, and 72 h. f, g Comparison of cell cycle distribution between the metformin group and control group by flow cytometry. In e, c, and g, **p < 0.01 by one-way ANOVA (n = 3 per group in d and f)

Back to article page